Literature DB >> 34390737

Pulmonary injury and oxidative stress in rats induced by inhaled sulfur mustard is ameliorated by anti-tumor necrosis factor-α antibody.

Rama Malaviya1, Alyssa Bellomo1, Elena Abramova1, Claire R Croutch2, Julie Roseman2, Rick Tuttle2, Eric Peters2, Robert P Casillas3, Vasanthi R Sunil1, Jeffrey D Laskin4, Debra L Laskin5.   

Abstract

Sulfur mustard (SM) is a bifunctional alkylating agent that causes severe injury to the respiratory tract. This is accompanied by an accumulation of macrophages in the lung and the release of the proinflammatory cytokine, tumor necrosis factor (TNF)α. In these studies, we analyzed the effects of blocking TNFα on lung injury, inflammation and oxidative stress induced by inhaled SM. Rats were treated with SM vapor (0.4 mg/kg) or air control by intratracheal inhalation. This was followed 15-30 min later by anti-TNFα antibody (15mg/kg, i.v.) or PBS control. Animals were euthanized 3 days later. Anti-TNFα antibody was found to blunt SM-induced peribronchial edema, perivascular inflammation and alveolar plasma protein and inflammatory cell accumulation in the lung; this was associated with reduced expression of PCNA in histologic sections and decreases in BAL levels of fibrinogen. SM-induced increases in inflammatory proteins including soluble receptor for glycation end products, its ligand, high mobility group box-1, and matrix metalloproteinase-9 were also reduced by anti-TNFα antibody administration, along with increases in numbers of lung macrophages expressing TNFα, cyclooxygenase-2 and inducible nitric oxide synthase. This was correlated with reduced oxidative stress as measured by expression of heme oxygenase-1 and Ym-1. Together, these data suggest that inhibiting TNFα may represent an efficacious approach to mitigating acute lung injury, inflammatory macrophage activation, and oxidative stress induced by inhaled sulfur mustard.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Lung toxicity; Oxidative stress; Sulfur mustard; Tumor necrosis factor α

Mesh:

Substances:

Year:  2021        PMID: 34390737      PMCID: PMC8452183          DOI: 10.1016/j.taap.2021.115677

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.460


  54 in total

1.  Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust.

Authors:  J Kim; L McKinley; S Natarajan; G L Bolgos; J Siddiqui; S Copeland; D G Remick
Journal:  Clin Exp Allergy       Date:  2006-01       Impact factor: 5.018

Review 2.  Biologics in Inflammatory Immune-mediated Systemic Diseases.

Authors:  Gianluca Moroncini; Giovanni Calogera; Devis Benfaremo; Armando Gabrielli
Journal:  Curr Pharm Biotechnol       Date:  2017       Impact factor: 2.837

3.  Inflammatory effects of inhaled sulfur mustard in rat lung.

Authors:  Rama Malaviya; Vasanthi R Sunil; Jessica Cervelli; Dana R Anderson; Wesley W Holmes; Michele L Conti; Ronald E Gordon; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-07-24       Impact factor: 4.219

4.  Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology.

Authors:  Neerad C Mishra; Jules Rir-sima-ah; Gary R Grotendorst; Raymond J Langley; Shashi P Singh; Sravanthi Gundavarapu; Waylon M Weber; Juan C Pena-Philippides; Matthew R Duncan; Mohan L Sopori
Journal:  Int Immunopharmacol       Date:  2012-03-28       Impact factor: 4.932

Review 5.  Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity.

Authors:  Barry Weinberger; Jeffrey D Laskin; Vasanthi R Sunil; Patrick J Sinko; Diane E Heck; Debra L Laskin
Journal:  Pulm Pharmacol Ther       Date:  2010-09-17       Impact factor: 3.410

6.  Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Vivianne L Verissimo; Jessica A Cervelli; Kinal N Vayas; LeRoy Hall; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2015-08-04       Impact factor: 4.849

7.  Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injury.

Authors:  Florian Guthmann; Heide Wissel; Bernd Rüstow
Journal:  Exp Lung Res       Date:  2009-11       Impact factor: 2.459

8.  A human monoclonal anti-TNF alpha antibody (adalimumab) reduces airway inflammation and ameliorates lung histology in a murine model of acute asthma.

Authors:  F Catal; E Mete; C Tayman; E Topal; A Albayrak; H Sert
Journal:  Allergol Immunopathol (Madr)       Date:  2014-06-02       Impact factor: 1.667

9.  Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer.

Authors:  Gaetano Caramori; Ian M Adcock; Paolo Casolari; Kazuhiro Ito; Elen Jazrawi; Loukia Tsaprouni; Gino Villetti; Maurizio Civelli; Chiara Carnini; Kian Fan Chung; Peter J Barnes; Alberto Papi
Journal:  Thorax       Date:  2011-04-02       Impact factor: 9.139

10.  RAGE is a Critical Mediator of Pulmonary Oxidative Stress, Alveolar Macrophage Activation and Emphysema in Response to Cigarette Smoke.

Authors:  Karl A Sanders; Don A Delker; Tom Huecksteadt; Emily Beck; Tanna Wuren; Yuntian Chen; Yuxia Zhang; Mark W Hazel; John R Hoidal
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.